OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical states of cirrhosis and competing risks
Gennaro D’Amico, Alberto Morabito, Mario D’Amico, et al.
Journal of Hepatology (2017) Vol. 68, Iss. 3, pp. 563-576
Closed Access | Times Cited: 408

Showing 1-25 of 408 citing articles:

Hepatocellular carcinoma
Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 4449

Hepatocellular Carcinoma
Augusto Villanueva
New England Journal of Medicine (2019) Vol. 380, Iss. 15, pp. 1450-1462
Closed Access | Times Cited: 3625

Burden of liver diseases in the world
Sumeet K. Asrani, Harshad Devarbhavi, John E. Eaton, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 1, pp. 151-171
Closed Access | Times Cited: 3038

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
María Reig, Alejandro Forner, Jordi Rimola, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 3, pp. 681-693
Open Access | Times Cited: 2753

Liver cirrhosis
Pere Ginés, Aleksander Krag, Juan G. Abraldeṣ, et al.
The Lancet (2021) Vol. 398, Iss. 10308, pp. 1359-1376
Closed Access | Times Cited: 955

Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Andrew M. Moon, Amit G. Singal, Elliot B. Tapper
Clinical Gastroenterology and Hepatology (2019) Vol. 18, Iss. 12, pp. 2650-2666
Open Access | Times Cited: 887

Global burden of liver disease: 2023 update
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 865

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen, Émilie Crouchet, Thomas F. Baumert
Cells (2020) Vol. 9, Iss. 4, pp. 875-875
Open Access | Times Cited: 851

Systemic treatment of hepatocellular carcinoma: An EASL position paper
Jordi Bruix, Stephen L. Chan, Peter R. Galle, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 4, pp. 960-974
Closed Access | Times Cited: 297

Current treatment of non‐alcoholic fatty liver disease
Rafael Paternostro, Michael Trauner
Journal of Internal Medicine (2022) Vol. 292, Iss. 2, pp. 190-204
Open Access | Times Cited: 166

Innate immune cells in cirrhosis
Christine Bernsmeier, Van der Merwe, Axel Périanin
Journal of Hepatology (2020) Vol. 73, Iss. 1, pp. 186-201
Open Access | Times Cited: 151

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy
Mattias Mandorfer, K Kozbial, Philipp Schwabl, et al.
Hepatology (2019) Vol. 71, Iss. 3, pp. 1023-1036
Open Access | Times Cited: 147

Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
Dalila Costa, Benedikt Simbrunner, Mathias Jachs, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 4, pp. 819-828
Open Access | Times Cited: 141

Oxidative Stress in Liver Pathophysiology and Disease
Abdolamir Allameh, Reyhaneh Niayesh‐Mehr, Azadeh Aliarab, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1653-1653
Open Access | Times Cited: 138

MAFLD: a multisystem disease
Rosaria Maria Pipitone, Carlo Ciccioli, G. Infantino, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 101

Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions
Yuanbin Liu, Mingkai Chen
World Journal of Gastroenterology (2022) Vol. 28, Iss. 41, pp. 5910-5930
Open Access | Times Cited: 91

Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease
Georg Semmler, Zhenwei Yang, Laurenz Fritz, et al.
Gastroenterology (2023) Vol. 165, Iss. 4, pp. 1041-1052
Open Access | Times Cited: 55

Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
Ashok Choudhury, Anand V. Kulkarni, Vinod Arora, et al.
Hepatology International (2025) Vol. 19, Iss. 1, pp. 1-69
Open Access | Times Cited: 2

Where does TIPS fit in the management of patients with cirrhosis?
Juan Carlos García‐Pagán, Saad Saffo, Mattias Mandorfer, et al.
JHEP Reports (2020) Vol. 2, Iss. 4, pp. 100122-100122
Open Access | Times Cited: 106

Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis
Laura Turco, Cándid Villanueva, Vincenzo La Mura, et al.
Clinical Gastroenterology and Hepatology (2019) Vol. 18, Iss. 2, pp. 313-327.e6
Open Access | Times Cited: 102

Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation
Yan Zhang, Baoyan Xu, Xianbo Wang, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 18, Iss. 11, pp. 2564-2572.e1
Open Access | Times Cited: 74

New clinical and pathophysiological perspectives defining the trajectory of cirrhosis
Rajiv Jalan, Gennaro D’Amico, Jonel Trebicka, et al.
Journal of Hepatology (2021) Vol. 75, pp. S14-S26
Open Access | Times Cited: 70

Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis
Qi Wang, Hong Zhao, You Deng, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1564-1572
Open Access | Times Cited: 57

Page 1 - Next Page

Scroll to top